Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Factors for lower walking speed in persons with multiple sclerosis.
Interleukin-6 control of early Theiler's Murine Encephalomyelitis Virus replication in macrophages occurs in conjunction with STAT1 activation and nitric oxide production.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Perceived stress in multiple sclerosis: the potential role of mindfulness in health and well-being.
[The process of meaning-making in adjustment to multiple sclerosis.]
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Development of the Cell Population in the Brain White Matter of Young Children.
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Acute disseminated encephalomyelitis (ADEM) following a H3N3 parainfluenza virus infection in a pregnant asthmatic woman with respiratory failure.
Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
The role of angiogenesis in the pathology of multiple sclerosis.
Quantifying progression of multiple sclerosis via classification of depth videos.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Epigenetics in NG2 glia cells.
Neuroradiological evaluation of demyelinating disease.
Promotion and prevention of autoimmune disease by CD8+ T cells.
Opexa Therapeutics provides MS trial enrollment update; 70% of patients enrolled
Images in clinical medicine. Bilateral internuclear ophthalmoplegia in multiple sclerosis.
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model.
LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.
Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis.
The putative role of endoplasmic reticulum aminopeptidases in autoimmunity: Insights from genomic-wide association studies.
[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : A review.]
Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Pages
« first
‹ previous
…
325
326
327
328
329
330
331
332
333
…
next ›
last »